Down-regulated genes |
PPAR signaling pathway |
1.01E-10 |
Metabolism of xenobiotics by cytochrome P450 |
7.55E-08 |
Insulin signaling pathway |
1.60E-07 |
Arachidonic acid metabolism |
9.85E-07 |
Linoleic acid metabolism |
1.14E-06 |
C21-steroid hormone metabolism |
3.95E-06 |
Pyruvate metabolism |
1.15E-05 |
Benzoate degradation via CoA ligation |
1.20E-05 |
Nitrogen metabolism |
2.21E-05 |
Glycolysis/gluconeogenesis |
2.34E-05 |
Glycine, serine, and threonine metabolism |
4.28E-05 |
Fatty acid metabolism |
5.03E-05 |
Starch and sucrose metabolism |
1.09E-04 |
Androgen and estrogen metabolism |
1.11E-04 |
Tyrosine metabolism |
2.88E-04 |
ABC transporters, general |
4.58E-04 |
Galactose metabolism |
7.13E-04 |
Butanoate metabolism |
8.94E-04 |
Fatty acid biosynthesis |
9.57E-04 |
Alkaloid biosynthesis II |
1.15E-03 |
|
Up-regulated genes |
Cell cycle |
6.57E-12 |
Focal adhesion |
1.51E-09 |
Tight junction |
1.01E-08 |
Pyrimidine metabolism |
1.38E-08 |
Regulation of actin cytoskeleton |
1.18E-07 |
Pancreatic cancer |
8.04E-07 |
Adherens junction |
1.25E-06 |
Amino sugars metabolism |
2.81E-06 |
MAPK signaling pathway |
1.36E-05 |
Ribosome |
3.69E-05 |
Leukocyte transendothelial migration |
8.21E-05 |
Proteasome |
9.34E-05 |
Huntington disease |
1.26E-04 |
B cell receptor signaling pathway |
1.61E-04 |
Chronic myeloid leukemia |
3.16E-04 |
Antigen processing and presentation |
4.30E-04 |
Gap junction |
5.37E-04 |
Glioma |
5.82E-04 |
Aminoacyl-tRNA biosynthesis |
8.98E-04 |
Apoptosis |
9.30E-04 |